|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 314.5 USD | +0.66% |
|
+1.97% | +9.21% |
| May. 20 | HSBC Adjusts Price Target on Amgen to $356 From $322 | MT |
| May. 20 | Amgen and AstraZeneca's Lung Disease Drug Study Reports Mixed Results | MT |
Sept 1 (Reuters) - The U.S. Federal Trade Commission has allowed Amgen Inc to move ahead with its $27.8 billion deal to buy Horizon Therapeutics, CNBC reported on Friday. (Reporting by Manas Mishra in Bengaluru)
| 1st Jan change | Capi. | |
|---|---|---|
| +9.21% | 168B | |
| +34.35% | 693B | |
| +29.39% | 584B | |
| -3.49% | 372B | |
| +20.15% | 332B | |
| +6.19% | 294B | |
| +14.11% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| -0.90% | 162B |
AMGEN INC. 
